Rare diseases
Investigational molecules
Locations
A study to evaluate the safety and effectiveness of BNT324 and BNT327 in patients with advanced lung cancer
FranceA study comparing the effectiveness and safety of datopotamab deruxtecan and docetaxel in adults with advanced or metastatic non-squamous non-small cell lung cancer
AustriaA study to evaluate the effectiveness of ciracigene golparvovec in children with Canavan disease
FranceA study to evaluate the use of FAPI-46 (68Ga) imaging to detect peritoneal cancer spread in patients with colorectal, gastric, ovarian, or pancreatic cancer
The NetherlandsStudy of budesonide suppositories to treat acute radiation proctitis in men with prostate cancer
AustriaFranceA study of psilocybin and psychological support compared to diphenhydramine hydrochloride for people with cocaine addiction
IrelandA study to evaluate the long-term safety of apremilast in children with oral ulcers from Behçet’s disease or juvenile psoriatic arthritis
GreeceA safety study of romosozumab in children and adolescents with osteogenesis imperfecta
AustriaA study to evaluate the long-term safety and effectiveness of mRNA-3927 in patients with Propionic Acidemia
FranceA study of enzomenib in adult patients with relapsed or refractory acute leukemia, including those with MLL rearrangement or NPM1 mutation.
BelgiumN1T-MC-MALO: A Master Protocol for a Randomized, Controlled, Clinical Trial of Multiple Pharmacologic Agents in Adult Participants With Metabolic Dysfunction-Associated Steatotic Liver Disease Who Are at Increased Risk of Developing Major Adverse Liver Outcomes (SYNERGY-Outcomes); N1T-MC-TZ01 Tirzepatide in participants with high-risk MASLD; N1T-MC-RT01 Retatrutide in participants with high-risk MASLD
AustriaTell us about your condition – we search every trial in Europe and connect you with the right site.
